A Study of an Implantable Miniature Telescope in Patients With With End-Stage AMD

A Prospective Multicenter Clinical Study of the Implantable Miniature Telescope* in Patients With Central Vision Impairment Associated With AMD: IMT-UK Protocol (*IMT by Dr. Isaac Lipshitz)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00555165

Enrollment

Registered

2007-11-07

Start date

2007-11-30

Completion date

2011-05-31

Last updated

2012-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Macular Degeneration

Keywords

Macular Degeneration, Visual Impairment, Quality of Life, Implantable Telescope

Brief summary

Evaluation of pre and post-implantation management of patients with end-stage age-related macular degeneration (AMD) who have been implanted with the implantable telescope (IMT) under CE Mark indicated use. This study is designed to evaluate in particular the optimal parameters for patient selection for use of this device in routine clinical practice.

Interventions

DEVICETelescope prosthesis

Monocular implantation of the telescope prosthesis after cataract extraction

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

55 Years to No maximum

Healthy volunteers

Inclusion criteria

CE Mark approved indication of use which includes * At least 55 years of age * Bilateral visual impairment due to geographic atrophy or disciform scars * Evidence of cataract

Exclusion criteria

* Active CNV (or 'wet' AMD) * Prior cataract or refractive surgery in the study eye

Design outcomes

Primary

Measure	Time frame
Best-Corrected Visual Acuity	1 year

Secondary

Measure	Time frame
Quality of Life	1 year

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026